The prognostic value of TP53 and tumor suppressor gene mutations in temozolomide-treated IDH1 mutant low-grade glioma

被引：0
|
作者：
Salem, Yahia E.
Abu Alragheb, Bayan O.
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-7361
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7361
引用
收藏
页数：2
相关论文
共 46 条
  • [31] Capitalizing on the absence of TP53 mutations in low-grade serous and clear cell ovarian cancer with XPO1 inhibition
    Nasioudis, Dimitrios
    Wang, Xiaolei
    Xu, Haineng
    Medvedev, Sergey
    Anderson, Matthew
    Shan Xiaoyin
    Kim, Hyoung
    Schwartz, Lauren
    Simpkins, Fiona
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S37 - S37
  • [32] Deregulation of the TP53/p14ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course
    Watanabe, T
    Katayama, Y
    Yoshino, A
    Komine, C
    Yokoyama, T
    CLINICAL CANCER RESEARCH, 2003, 9 (13) : 4884 - 4890
  • [33] Prognostic Value of Functional Subtype Classification of Co-Occurring TP53 Mutations in Patients with EGFR-Mutant NSCLC Treated with TKI
    Chukkalore, D.
    Pemmaraju, A.
    Lee, C. -S.
    Seetharamu, N.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S629 - S630
  • [34] IDH1 R132H and TP53 R248Q Mutations Modulate Glioma Cell Migration and Adhesion on Different ECM Components
    Shmelev, Mikhail E.
    Pilnik, Andrei A.
    Shved, Nikita A.
    Penkova, Alina O.
    Gulaia, Valeriia S.
    Kumeiko, Vadim V.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)
  • [35] Prognostic value of MGMT methylation, TP53 mutation, and MDM2, EGFR, or CDK4 amplification in malignant glioma patients treated with adjuvant temozolomide chemotherapy
    Luyken, C
    Loeser, S
    Blaschke, B
    Köhler, S
    Kreuzmann, A
    Seghrouchni, S
    Reifenberger, G
    Sabel, M
    NEURO-ONCOLOGY, 2005, 7 (03) : 328 - 328
  • [36] Incidence and prognostic value of TP53 mutations in IPSS low and INT 1 (lower risk) MDS with del 5q
    Bally, C.
    Ades, L.
    Renneville, A.
    Preudhomme, C.
    Raynaud, S.
    Cluzeau, T.
    Eclache, V.
    Hunault-Berger, M.
    Stamoullas, A.
    Fontenay, M.
    Mozziconacci, M. J.
    De The, H.
    Fenaux, P.
    Lehmann-Che, J.
    LEUKEMIA RESEARCH, 2013, 37 : S32 - S33
  • [37] Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of “dual-genotype” IDH-mutant infiltrating gliomas
    Cinthya J. Zepeda-Mendoza
    Rachael A. Vaubel
    Shabnam Zarei
    Cristiane M. Ida
    Martin Matthews
    Sara Acree
    Aditya Raghunathan
    Caterina Giannini
    Robert B. Jenkins
    Acta Neuropathologica, 2020, 139 : 1105 - 1107
  • [38] Concomitant 1p/19q co-deletion and IDH1/2, ATRX, and TP53 mutations within a single clone of "dual-genotype" IDH-mutant infiltrating gliomas
    Zepeda-Mendoza, Cinthya J.
    Vaubel, Rachael A.
    Zarei, Shabnam
    Ida, Cristiane M.
    Matthews, Martin
    Acree, Sara
    Raghunathan, Aditya
    Giannini, Caterina
    Jenkins, Robert B.
    ACTA NEUROPATHOLOGICA, 2020, 139 (06) : 1105 - 1107
  • [39] DIRECT IN VIVO CRISPR SCREEN IDENTIFIES COOPERATING TUMOR SUPPRESSORS THAT DRIVE PROGRESSION OF IDH1-MUTANT LOW-GRADE GLIOMA TO AGGRESSIVE GLIOBLASTOMA
    Yanchus, Connor
    Drucker, Kristen
    Kollmeyer, Thomas
    Tsai, Ricky
    Jiang, Lingyan
    Ali, Asma
    Carson, Brittany
    Pawling, Judy
    Malik, Ahmad
    Al-Zahrani, Khalid
    Loganathan, Sampath Kumar
    Fortin, Jerome
    Zhou, Lily
    Elia, Andrew
    Dennis, James W.
    Mak, Tak
    Taylor, Michael
    Zadeh, Gelareh
    Dirks, Peter
    Jenkins, Robert
    Schramek, Daniel
    NEURO-ONCOLOGY, 2021, 23 : 219 - 219
  • [40] Clinicopathological associations and prognostic values of IDH1 gene mutation, MGMT gene promoter methylation, and PD-L1 expressions in high-grade glioma treated with standard treatment
    July, Julius
    Patricia, Diana
    Gunawan, Pricilla Yani
    Setiajaya, Handrianto
    Ginting, Teridah Ernala
    Putra, Teguh Pribadi
    Wuisan, Zerlina
    Budhiarko, Dini
    Masykura, Najmiatul
    Prayogi, Gintang
    Utomo, Ahmad Rusdan
    Tandean, Steven
    Loe, Michael Lumintang
    PAN AFRICAN MEDICAL JOURNAL, 2020, 36 : 1 - 13
12345